DYADIC INTERNATIONAL INC(NASDAQ:DYAI) stock News

DYAI Latest News, Press Relases and Analysis

All

Press Releases

8 days ago - By: Benzinga - Mentions: KPTI ICU KALV SXTC ...

12 Health Care Stocks Moving In Wednesday's After-Market Session

a month ago - By: Dyadic International, Inc.

Dyadic to Present at Investor Conferences and BPI East

2 months ago - By: The Motley Fool

Dyadic International Narrows Q2 Loss

2 months ago - By: The Motley Fool

Dyadic (DYAI) Q2 2025 Earnings Call Transcript

2 months ago - By: Benzinga

A Look at Dyadic International's Upcoming Earnings Report

2 months ago - By: Dyadic International, Inc.

Dyadic Reports Second Quarter 2025 Financial Results and Highlights of Recent Company Progress

2 months ago - By: Dyadic International, Inc.

Dyadic to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025

2 months ago - By: Dyadic International, Inc.

Dyadic to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025

2 months ago - By: Dyadic International, Inc.

UPDATE: Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock

2 months ago - By: Dyadic International, Inc.

UPDATE: Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock

2 months ago - By: Dyadic International, Inc.

Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock

2 months ago - By: Dyadic International, Inc.

Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock

2 months ago - By: Dyadic International, Inc.

Dyadic International, Inc. Announces Proposed Public Offering of Common Stock

2 months ago - By: Dyadic International, Inc.

Dyadic International, Inc. Announces Proposed Public Offering of Common Stock

3 months ago - By: Dyadic Applied BioSolutions

Dyadic International, Inc. Announces Strategic Rebrand to Dyadic Applied BioSolutions

4 months ago - By: Dyadic International, Inc.

Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift to Focus on High Demand Ancillary Proteins for Life Sciences, Nutrition, and Industrial Applications

4 months ago - By: Dyadic International, Inc.

Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift to Focus on High Demand Ancillary Proteins for Life Sciences, Nutrition, and Industrial Applications

5 months ago - By: Dyadic International, Inc.

Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025

5 months ago - By: Dyadic International, Inc.

Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025

6 months ago - By: Dyadic International, Inc.

Dyadic to Present at World Vaccine Congress | Washington

6 months ago - By: Dyadic International, Inc.

Dyadic to Present at World Vaccine Congress | Washington

6 months ago - By: Dyadic International, Inc.

Dyadic Reports 2024 Year-End Financial Results and Business Updates

7 months ago - By: Dyadic International, Inc.

Dyadic Announces Funding Award from CEPI to Use C1 to Accelerate Development of Protein-Based Vaccines

7 months ago - By: Dyadic International, Inc.

Dyadic Announces Funding Award from CEPI to Use C1 to Accelerate Development of Protein-Based Vaccines

7 months ago - By: Dyadic International, Inc.

Dyadic to Report 2024 Full Year Financial Results and Host Conference call on Wednesday, March 26, 2025

7 months ago - By: Dyadic International, Inc.

Dyadic to Report 2024 Full Year Financial Results and Host Conference call on Wednesday, March 26, 2025

7 months ago - By: Dyadic International, Inc.

DYADIC INTERNATIONAL INC (DYAI) Stock News

DYAI Latest News, Press Relases and Analysis

12 Health Care Stocks Moving In Wednesday's After-Market Session

Dyadic to Present at Investor Conferences and BPI East

Dyadic International Narrows Q2 Loss

Dyadic (DYAI) Q2 2025 Earnings Call Transcript

A Look at Dyadic International's Upcoming Earnings Report

Dyadic Reports Second Quarter 2025 Financial Results and Highlights of Recent Company Progress

Dyadic to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025

Dyadic to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025

UPDATE: Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock

UPDATE: Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock

Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock

Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock

Dyadic International, Inc. Announces Proposed Public Offering of Common Stock

Dyadic International, Inc. Announces Proposed Public Offering of Common Stock

Dyadic International, Inc. Announces Strategic Rebrand to Dyadic Applied BioSolutions

Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift to Focus on High Demand Ancillary Proteins for Life Sciences, Nutrition, and Industrial Applications

Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift to Focus on High Demand Ancillary Proteins for Life Sciences, Nutrition, and Industrial Applications

Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025

Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025

Dyadic to Present at World Vaccine Congress | Washington

Dyadic to Present at World Vaccine Congress | Washington

Dyadic Reports 2024 Year-End Financial Results and Business Updates

Dyadic Announces Funding Award from CEPI to Use C1 to Accelerate Development of Protein-Based Vaccines

Dyadic Announces Funding Award from CEPI to Use C1 to Accelerate Development of Protein-Based Vaccines

Dyadic to Report 2024 Full Year Financial Results and Host Conference call on Wednesday, March 26, 2025

Dyadic to Report 2024 Full Year Financial Results and Host Conference call on Wednesday, March 26, 2025

Dyadic to Attend Multiple Industry Events in March